/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

style
pb-0

Quest Diagnostics Inc.

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0
$182.7 0.0003(0.03%) DGX at 04 Dec 2025 04:29 PM Diagnostics & Research
Lowest Today 182.24
Highest Today 183.99
Today’s Open 183.27
Prev. Close 182.55
52 Week High 197.55
52 Week Low 146.30
Day’s Range: Low 182.24 High 183.99
52-Week Range: Low 146.30 High 197.55
1 day return -
1 Week return -3.56
1 month return +2.58
3 month return +1.39
6 month return +5.05
1 year return +14.07
3 year return +22.62
5 year return +48.08
10 year return -

Institutional Holdings

Vanguard Group Inc 12.73

BlackRock Inc 9.22

T. Rowe Price Associates, Inc. 6.43

State Street Corp 4.64

JPMorgan Chase & Co 3.87

Vanguard Total Stock Mkt Idx Inv 3.14

Boston Partners Global Investors, Inc 2.72

Geode Capital Management, LLC 2.67

Victory Capital Management Inc. 2.51

Vanguard 500 Index Investor 2.47

Vanguard Mid Cap Index Institutional 2.23

Morgan Stanley - Brokerage Accounts 1.92

Dimensional Fund Advisors, Inc. 1.70

Victory Sycamore Established Value R 1.70

Wells Fargo & Co 1.64

Grantham, Mayo, Van Otterloo & Co., LLC 1.56

Amvescap Plc. 1.48

Bank of America Corp 1.43

Wellington Management Company LLP 1.43

Fidelity 500 Index 1.27

Davis Selected Advisers 1.21

SPDR® S&P 500® ETF 1.21

iShares Core S&P 500 ETF 1.20

NORGES BANK 1.19

JPMorgan Equity Income I 1.16

JPM US Equity Income-Composite 1.16

JHancock Disciplined Value I 1.13

AllianceBernstein L.P. 1.11

FMR Inc 1.10

UBS Asset Mgmt Americas Inc 1.09

T. Rowe Price U.S. Value Equity Tr-D 1.03

JPMorgan Mid Cap Value L 1.01

Vanguard Windsor Investor Shares 1.00

JPM US Mid Cap Value-Composite 0.99

T. Rowe Price U.S. Large-Cap Core Tr-C 0.94

T. Rowe Price Dividend Growth 0.93

T. Rowe Price US Dividend Growth Eq Comp 0.93

Vanguard Value Index Inv 0.88

T. Rowe Price US Large-Cap Core 0.88

T. Rowe Price US Large-Cap Core Eq Comp 0.88

Market Status

Strong Buy: 8

Buy: 1

Hold: 10

Sell: 0

Strong Sell: 0

Fundamentals

Market Cap 20413.37 M

PB Ratio 2.8166

PE Ratio 21.4009

Enterprise Value 26393.01 M

Total Assets 16153.00 M

Volume 1057340

Company Financials

Annual Revenue FY24:9872000000 9872.0M, FY23:9297000000 9297.0M, FY22:9883000000 9883.0M, FY21:10788000000 10788.0M, FY20:9437000000 9437.0M

Annual Profit FY24:3244000000 3244.0M, FY23:3075000000 3075.0M, FY22:3433000000 3433.0M, FY21:4209000000 4209.0M, FY20:3633000000 3633.0M

Annual Net worth FY24:871000000 871.0M, FY23:763000000 763.0M, FY22:946000000 946.0M, FY21:1995000000 1995.0M, FY20:1431000000 1431.0M

Quarterly Revenue Q3/2025:2816000000 2816.0M, Q2/2025:2761000000 2761.0M, Q1/2025:2652000000 2652.0M, Q4/2024:2621000000 2621.0M, Q3/2024:2488000000 2488.0M

Quarterly Profit Q3/2025:949000000 949.0M, Q2/2025:943000000 943.0M, Q1/2025:863000000 863.0M, Q4/2024:858000000 858.0M, Q3/2024:811000000 811.0M

Quarterly Net worth Q3/2025:245000000 245.0M, Q2/2025:282000000 282.0M, Q1/2025:220000000 220.0M, Q4/2024:222000000 222.0M, Q3/2024:226000000 226.0M

Fund house & investment objective

Company Information Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, emerging retail healthcare providers, pharmaceutical companies and insurers, commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Organisation Diagnostics & Research

Employees 45000

Industry Diagnostics & Research

CEO Mr. James E. Davis

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow